谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Efficacy and Safety of Everolimus Plus Exemestane in Patients with Hormone Receptor-Positive, HER-2-negative Advanced Breast Cancer: Results from the Open-Label, Multicentre, Non-Interventional BRAWO Study

Diana Lueftner,Florian Schuetz,Andreas Schneeweiss,Andreas Hartkopf,Wilhelm Bloch,Thomas Decker,Christoph Uleer,Oliver Stoetzer,Frank Foerster,Marcus Schmidt,Christoph Mundhenke,Hans Tesch,Christian Jackisch, Thomas Fischer,Julia Kreuzeder,Gernot Guderian,Peter A. Fasching

INTERNATIONAL JOURNAL OF CANCER（2024）

引用 0|浏览26
暂无评分
关键词
advanced breast cancer,everolimus,exemestane,HER2-,HR plus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要